Literature DB >> 10090450

Toxicity and efficacy of intravitreal injection of spartanamicin B in the treatment of Candida endophthalmitis.

P D Serracarbassa1, G A Peyman, C Liang, N Calixto, M G Nair.   

Abstract

AIMS/
BACKGROUND: We evaluated the retinal toxicity of spartanamicin B and its efficacy in a rabbit model of Candidal endophthalmitis.
METHODS: Toxicity. Fourteen albino rabbit eyes were injected intravitreally with spartanamicin B (1, 2, 5, 10, 25, 50, and 100 microg); 2 eyes received the vehicle alone. Efficacy. Ten rabbit eyes were inoculated with 3000 Candida organisms which caused endophthalmitis in 24 hours. Eight eyes were treated with intravitreal spartanamicin B in doses of 1, 2, 5, or 10 microg/0.1 ml; 2 untreated eyes served as controls.
RESULTS: Toxicity. The eyes injected with < or =10 microg and the control group eyes exhibited no clinical, histological, or electroretinographic evidence of retinal toxicity. Doses >10 microg caused vitritis. Efficacy. Clinical examination of the treated eyes showed a gradual improvement over 3-6 days; mild opacities remained until day 14. Results of cultures performed 15 days after infection were negative in all treated eyes.
CONCLUSIONS: Intravitreally injected spartanamicin B (10 microg) is nontoxic to the retina, effective against C. albicans in the endophthalmitis model in the rabbit eye and caused no discernible histological changes in the retina.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10090450     DOI: 10.1023/a:1006191629625

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  7 in total

1.  Therapy of experimental intraocular Aspergillus infection.

Authors:  B S FINE; L E ZIMMERMAN
Journal:  Arch Ophthalmol       Date:  1960-12

2.  Intravitreal amphotericin B treatment of experimental fungal endophthalmitis.

Authors:  A J Axelrod; G A Peyman
Journal:  Am J Ophthalmol       Date:  1973-10       Impact factor: 5.258

3.  Toxicity of intravitreal injection of amphotericin B.

Authors:  A J Axelrod; G A Peyman; D J Apple
Journal:  Am J Ophthalmol       Date:  1973-10       Impact factor: 5.258

4.  Endogenous fungus endophthalmitis due to Candida albicans.

Authors:  A Tarkkanen; V Tommila; O Valle; I Raivio
Journal:  Br J Ophthalmol       Date:  1967-03       Impact factor: 4.638

5.  Intravitreal corticosteroids in the treatment of exogenous fungal endophthalmitis.

Authors:  M L Coats; G A Peyman
Journal:  Retina       Date:  1992       Impact factor: 4.256

6.  Retinal toxicity of intravitreally injected faeriefungin.

Authors:  W A Dunlap; M Karaçorlu; G A Peyman; M G Nair; M Rahimy; L Pedroza
Journal:  Ophthalmic Surg       Date:  1994-05

7.  Antifungal anthracycline antibiotics, spartanamicins A and B from Micromonospora spp.

Authors:  M G Nair; S K Mishra; A R Putnam; R C Pandey
Journal:  J Antibiot (Tokyo)       Date:  1992-11       Impact factor: 2.649

  7 in total
  3 in total

1.  Evaluating retinal toxicity of intravitreal caspofungin in the mouse eye.

Authors:  Deb K Mojumder; Francis A Concepcion; Shil K Patel; Andrew J Barkmeier; Petros E Carvounis; John H Wilson; Eric R Holz; Theodore G Wensel
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

Review 2.  The genus Micromonospora as a model microorganism for bioactive natural product discovery.

Authors:  Mohamed S Hifnawy; Mohamed M Fouda; Ahmed M Sayed; Rabab Mohammed; Hossam M Hassan; Sameh F AbouZid; Mostafa E Rateb; Alexander Keller; Martina Adamek; Nadine Ziemert; Usama Ramadan Abdelmohsen
Journal:  RSC Adv       Date:  2020-06-08       Impact factor: 4.036

3.  Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.

Authors:  Hua Gao; Mark Pennesi; Kekul Shah; Xiaoxi Qiao; Seenu M Hariprasad; William F Mieler; Samuel M Wu; Eric R Holz
Journal:  Trans Am Ophthalmol Soc       Date:  2003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.